Latest Breaking News On - Constellation pharma - Page 1 : comparemela.com
Novartis to buy cancer treatment developer MorphoSys for $2 9 billion
oklahomacitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oklahomacitysun.com Daily Mail and Mail on Sunday newspapers.
Drugmaker Novartis to acquire MorphoSys for $2 9 billion
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Novartis to acquire cancer-focused MorphoSys for 2 7 billion euros
businesstimes.com.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstimes.com.sg Daily Mail and Mail on Sunday newspapers.
Reuters first reported on Monday that Switzerland-based Novartis was in advanced talks to acquire MorphoSys, leading to the German biotech firm's shares surging more than 40%. The Swiss group will offer shareholders 68.00 euros per share in cash and take MorphoSys private after the deal, which is contingent on certain conditions, including a minimum acceptance threshold of 65% of MorphoSys' share capital and regulatory clearances, the companies said.
Novartis to acquire cancer-focused MorphoSys for $2 9 billion By Reuters
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.